Clinical Trial Update: Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial evaluating an ophthalmic solution for loss of visual function due to age-related nuclear cataract.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nuclear Cataract

Snippet

Sponsor: Chakshu Research, Inc. | Conditions: Nuclear Cataract | Phase 2 | Status: UNKNOWN